%0 Case Reports
%T Latent Mastocytosis Triggered by COVID-19 Vaccination: A Case Report.
%A Calogiuri G
%A Foti C
%A Congedo M
%A Nettis E
%A Paladini L
%A Greco G
%A Pavone V
%A Vacca A
%J Endocr Metab Immune Disord Drug Targets
%V 24
%N 4
%D 2024 Oct 10
%M 37817657
%F 2.387
%R 10.2174/0118715303241179230927105454
%X <B>BACKGROUND: </B>Hereby, we describe the first case of latent mastocytosis triggered by mRNA-based vaccine to prevent COVID-19 infection.<BR><B>METHODS: </B>In a 42-year-old Arabian man affected by slight, undiagnosed mastocytosis, the second dose of the COVID-19 vaccine made more blatant his latent disease. The postvaccination diagnostic iter is illustrated and the potential reasons causing the onset of the cutaneous mastocytosis are discussed.<BR><B>CONCLUSIONS: </B>Clinicians should keep a longer follow-up of their patients after the COVID-19 vaccination, not related to few hours, for the risk of immediate-type adverse events only.